Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI

NCT04232657 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT04232657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04232657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
Lead sponsor
VA Office of Research and Development
Phase
Phase 2
Overall status
Completed
Start date
March 1, 2021
Completion date
August 24, 2026
Enrollment
36 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

spinal cord injury (=3 years), sublesional bone loss secondary to sci